Independent Director · Jazz Pharmaceuticals plc (JAZZ)

Anne O'Riordan director compensation at Jazz Pharmaceuticals: $496K

Fiscal year 2025 director compensation for Anne O'Riordan at Jazz Pharmaceuticals plc. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed June 8, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Anne O'Riordan’s full pay file as a PDF — free

More than this page: up to 10 years of Anne’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Anne O'Riordan and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Jazz Pharmaceuticals Director Compensation Table · all 5 fiscal years held
In US dollars, as Jazz Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$102,500$393,064——$495,564
FY2024$101,087$422,573$0$0$523,660
FY2023$95,269$428,501——$523,770
FY2022$81,744$393,677——$475,421
FY2021$75,000$383,145$0—$458,145

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Jazz Pharmaceuticals plc DEF 14A filed June 8, 2026, accession 0001232524-26-000029, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Jazz Pharmaceuticals plc filed document, accession 0001232524-26-000029. Every figure is read from that document and cited to the page and table it appears in. Filed June 8, 2026.

Get the Jazz Pharmaceuticals Board Governance Report

$495,564 Anne O'Riordan, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of June 8, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Jazz Pharmaceuticals pays directors a $75,000 cash retainer and $400,000 in equity.

The rest of the Jazz Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Heather Ann McSharryIndependent Director$528,064
Jennifer E. CookIndependent Director$520,564
Laura J. HamillIndependent Director$480,564
Mark D. SmithIndependent Director$490,564
Norbert G. RiedelIndependent Director$518,064
Patrick G. EnrightIndependent Director$495,564
Patrick KennedyIndependent Director$503,064
Rick E WinninghamLead Independent Director$555,564
Seamus C. MulliganIndependent Director$500,564
Ted W. LoveIndependent Director$8,542

The full Jazz Pharmaceuticals compensation record

free company brief

This page is one director within Jazz Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Jazz Pharmaceuticals proxy · each links to its own free brief

Order JAZZ

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report